Scientific Advisory Board
JC’S SCIENTIFIC ADVISORY BOARD
Dr. Kenneth Blum, B.Sc., M.Sc., PhD, DHL
CHAIR
CENTER FOR SPORTS, EXERCISE & MENTAL HEALTH , WESTERN UNIVERSITY HEALTH SCIENCES, POMONA, CALIFORNIA AND DEPARTMENT OF MOLECULAR BIOLOGY, ADELSON SCHOOL OF MEDICINE, ARIEL UNIVERSITY, ARIEL, ISRAEL. (psychiatric genetics & pharmacogenomics – EIC Current Psychopharmacology and CRC Press -Editor –BODY RECOMPOSITION: A Comprehensive and Metabolic Alternative to Weight Loss)
Kenneth Blum is a well-known American Scientist recognized for his work related to Psychopharamcology and Psychiatric Genetics. He received a B. Sc. degree in Pharmaceutical Science from Columbia University (NYC); a master’s in medicine from New Jersey College of Medicine (Rutgers) and a PhD in Neuropharmacology from New York Medical College. He completed genetic fellowship at Colorado University at boulder. He is the recipient of many honors and awards including the Marquis Who’s Who -Distinguished Top Professional featured in the Wall Street Journal. DR. Blum has published over 740 peer reviewed articles, book chapters and meeting abstracts with 19 books with over 18,000 citations and 185,000 reads worldwide. He has distinguished himself and credited with the first genetic association of the Dopamine D2 receptor gene and severe alcoholism published in JAMA, 1990. He is considered by some to be the Father of Psychiatric Genetics. In 1995, Dr. Blum coined the term “Reward Deficiency Syndrome(RDS)” and developed the USA and Foreign patented “Genetic Addiction Risk Severity”(GARS) test. Dr. Blum has also developed patented Pro-dopamine regulators in USA and Europe. His overall patent portfolio consists of 100 patents worldwide. Dr. Blum is the Editor -in-Chief for a number of academic journals including Current Psychopharmacology , Addiction Psychiatry, and Theranostic and Pharmacological Sciences. He also serves as Associate Editor for Frontiers in Psychiatry and Frontiers in Public Health both related to the section on Substance Use Disorder and Genes, Protein & disease. He is also serving as guest EIC on a collective for Psychology & Psychological Management and Cellular Molecular Neurobiology. He serves on 23 peer reviewed journals and is regional editor for Current Pharmaceutical & Biotechnology. Dr. Blum is also the founding President of the United Scientific Group, an academic publishing house. His work has been featured in all the major media outlets worldwide and in 1990 his work on genetics was in the top 25 most important discoveries in science by Discovery Magazine. He is the recipient on NIH grants and has been awarded Lifetime Achievements, distinguished Honorary Doctors of Humane Letters ; Life-time Honorary Professor at ELTE Eötvös Loránd University, Hungary and Distinguished Honorary Professor at Adelson School of Medicine, Ariel University, Israel. Currently, besides faculty positions as adjunct professor (Western University , University of Vermont, Wright School of Medicine), he is the Executive Chairman and CEO of TranspliceGen Therapeutics, Inc. Stanford university credited him as top 2% World Best scientist list (2023). DR. Blum also serves on a number of scientific boards including the Center for Advanced Spine Care of Southern Arizona, Cross-Cultural Research and Educational Institute, Awareness Integration Institute, Quiet Mind Foundation, and Sunder Foundation. Dr. Blum also serves as scientific advisor for Electronic Waveform Lab, Victory Nutrition International, and Peak logic. Dr. Blum is a member of the Society of Brain Mapping & Therapeutics (SMBMT) . Most recently the International Research Awards on Neurology and Neuro Disorders awarded him as “Best Researcher Award 2023. DR Blum has been recently nominated for the KEIO Medical & Science PRIZE (THE JAPANESE EQUIVALENT TO THE NOBEL PRIZE) 2024.
DEBRA C MASH, PHD
CO-CHAIR
PROFESSOR EMERITA UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE, DEPTS. NEUROLOGY AND MOLECULAR AND CELLULAR Pharmacology (Neuroscience)
SCIENTIFIC ADVISORY BOARD MEMBERS
Dr. Foojan Zeine
BOARD MEMBER
Dr. Foojan Zeine is an International Speaker, Author, and Psychotherapist. She has her Doctorate in Clinical Psychology and is a Licensed Marriage & Family Therapist. She has obtained a graduate certificate in the Topic of Human Behavior from the Harvard Extension School (HES). Her expertise is in Intimate Relations and Addictive Behaviors. She has extensive experience treating Depression, Anxiety, Traumas, and Domestic Violence. Foojan presents internationally and is a leading expert in Online Therapy. She has published numerous research articles in psychology and human behavior. She is the originator and the author of Awareness Integration Theory (AIT), a multi-modality Psychology and Educational approach and intervention toward minimizing Depression and anxiety while improving Self-esteem and Self-confidence. She founded the International Awareness Integration Institute, which conducts training workshops to educate and certify psychotherapists, coaches, and teachers in this approach. She is the co-founder of “Foojan” App offering AIT to the public globally. She teaches AIT as a lecturer/ professor at the California State University Long Beach and Université Paris Cité. She is the author and co-author of 6 books and ten peer-reviewed journal publications. She hosts the Inner Voice – A Heartfelt Chat with Dr. Foojan Podcast. She is a guest speaker at many universities, including Harvard, MIT, UCLA, USC, UC Santa Barbara, Chicago University, and Cal State Long Beach.
Prof. Dr. Bowirrat Abdalla M.D., Ph.D.
BOARD MEMBER
Prof. Dr. Bowirrat Abdalla M.D., Ph.D. is a Full Professor at Adelson School of Medicine & at Department of Molecular Biology, Ariel University, Israel. He attained his MD from Rome University, “La Sapienza” with Excellency, and he has attained his residency in Clinical Neurology from Queen square – National Institute of Neurology and Neurosurgery, London University, UK.
His PhD he received from Tel-Aviv University, Israel in the field of Neuroscience with excellency too, and his postdoctoral studies were performed at Boston University school of Medicine in the field of Human Genetics, USA.
He received his Professorship from Boston University in Psychiatry (Behavioral Neuroscience Department). He had published more than 180 manuscripts and 10 books & chapters in reputed journals and he is serving as an editorial board of member of famous medical journals. Furthermore, he received many international awards including the Bruce S. Schoenberg international award in Neuroepidemiology of AD from the American Academy of Neurology, and in 2019 was selected as “Professor of the Year” from Venus International foundation, India. In 2022 he received a certificate of Honorary faculty position from the Institute of integrative OMICS and applied Biotechnology, India.
Prof. Bowirrat’s researches focus is on enhancing health outcomes, looking for novel treatment for neurological, psychiatric, Neuroinflammatory diseases, Addiction and various genetic disorders. He is involved in academic and researches in different medical fields in addition to his wide activity in teaching. He was invited as a speaker in different national and international conferences and was awarded the best lecturer in Neuroepidemiology from the American Academy of Neurology and also was awarded the Second Boston Scientific poster from Boston University School of Medicine. Prof. Bowirrat received the biggest Grant from the NIH – USA, $1.2 million to study and search Neurodegeneration (1996-2002). Prof. Bowirrat has also wide collaboration studies in the Lab. of Prof. Kenneth Blum, CA -USA, especially looking for underlying etiology of addiction, different substance abuse, Genetic tests for diagnosis, prevention, treatment of addiction.
Prof. Dr. Bowirrat Abdalla M.D., DcN., BA., Ph.D. Adelson School of Medicine & Department of Molecular Biology. Ariel University, Ariel 40700, Israel. Residency: 28 Meir Rutberg Street, Haifa, Israel Mobile: +972 54 6693763 Fax: +972 4 6356133 Email: bowirrat@gmail.com Email: abdallab@ariel.ac.il Https://www.ariel.ac.il/wp/bio/ https://orcid.org/0000-0001-8185-0688
Igor Elman, MD
BOARD MEMBER
DEPARTMENT OF PSYCHIATRY – HARVARD UNIVERSITY SCHOOL OF MEDCINE, CAMBRIDGE, MA., USA (Neuroscience & Pain Management – EIC-Journal Psychology Research & Behavioral Management)
Igor Elman, MD, is a Board-Certified Psychiatrist with a subspecialty certification in Addiction Psychiatry. Dr. Elman earned his medical degree from the Ben-Gurion University. Following residency and fellowships training at the Albert Einstein College of Medicine in New York, at the National Institute of Mental Health and at the Massachusetts General Hospital, Dr. Elman has been on the faculty of Harvard Medical School for 20 years. He has held two Professor and Chair positions in the Department of Psychiatry at the Wright State University Boonshoft School of Medicine and Cooper Medical School, Rowan University. He serves as the Editor-in-Chief for the Journal of Psychology Research and Behavior Management and as the Special Issues’ Editor for Psychiatry Research. Dr. Elman’s broad research interests focus on understanding the interplay between stress, reward, and metabolic systems and their impact on neuropsychiatric and medical disorders, including addiction, post-traumatic stress disorder, schizophrenia, obesity, and pain.
Debasis Bagchi, PhD, MACN, FRSM, CNS, FISNFF, CFFS, MAIChE
BOARD MEMBER
DEPARTMENT OF PHARMACEUTICAL SCIENCES, TEXAS SOUTHERN UNIVERSITY COLLEGE OF PHARMACY, HOUSTON, TX, USA (Microbiome research and CRC Press -Editor –BODY RECOMPOSITION: A Comprehensive and Metabolic Alternative to Weight Loss)
Debasis Bagchi, PhD, MACN, FRSM, CNS, FISNFF, CFFS, MAIChE, received his Ph.D. in Medicinal Chemistry in 1982. He is the Director of Innovation & Clinical Affairs, Dr. Herbs LLC, Concord, CA; an Adjunct Professor in the College of Pharmacy & Health Sciences, Texas Southern University, Houston, TX; an Adjunct Faculty in the Department of Biology, Adelphi University, Garden City, NY, and the Course Director of Neurotoxicology (BIO 585); an Adjunct Faculty in the Department of Psychology, Gordon F. Derner School of Psychology, Adelphi University, Garden City, NY, and the Course Co-Director of Integrative Neuroscience Seminar (PIA395-001). Dr. Bagchi is the ex-Professor in the Department of Pharmacological and Pharmaceutical Sciences at the University of Houston College of Pharmacy, Houston, TX. He served as the Chief Scientific Officer at Cepham Inc, Belmont, NJ, from June 2013, till Dec 2018, and as the Director of Scientific Affairs, VNI Inc., Bonita Springs, FL, from Jan 2019 to Jan 2023. He served as the Senior Vice President of Research & Development of InterHealth Nutraceuticals Inc, Benicia, CA, from 1998 till Feb 2011; Director of Innovation and Clinical Affairs, of Iovate Health Sciences, Oakville, ON, till June 2013. Dr. Bagchi received the Master of American College of Nutrition Award in October 2010; became a Fellow of ISNFF in 2021 and awarded a Fellow of Royal Society of Medicine (FRSM) in 2022. He is the Past Chairman of International Society of Nutraceuticals and Functional Foods (ISNFF), Past President of American College of Nutrition, Clearwater, FL, and Past Chair of the Nutraceuticals and Functional Foods Division of Institute of Food Technologists (IFT), Chicago, IL. He is serving as a Distinguished Advisor on the Japanese Institute for Health Food Standards (JIHFS), Tokyo, Japan. Dr. Bagchi is a Member of the Study Section and Peer Review Committee of the National Institutes of Health (NIH), Bethesda, MD. Dr. Bagchi has 448 papers in peer reviewed journals, 48 books and 20 patents. Dr. Bagchi is also a Member of the Society of Toxicology, Member of the New York Academy of Sciences, Fellow of the Nutrition Research Academy, and Member of the TCE stakeholder Committee of the Wright Patterson Air Force Base, OH. Dr. Bagchi is the Associate Editors of the Journal of Functional Foods, Journal of the American College of Nutrition, and Archives of Medical and Biomedical Research, and also serving as Editorial Board Member of numerous peer reviewed journals, including Antioxidants & Redox Signaling, Cancer Letters, Food & Nutrition Research, Toxicology Mechanisms and Methods, The Original Internist, and other peer reviewed journals.
Member of the Editorial Boards: Journal of American College of Nutrition (Associate Editor); Journal of Functional Foods (Past Associate Editor); American Journal of Biopharmacy and Pharmaceutical Sciences (Associate Editor); Food & Nutrition Research; Toxicology Mechanisms and Methods; Antioxidants & Redox Signaling & Others Fellow/Member of the Professional Societies: Master American College of Nutrition Fellow Royal Society of Medicine American College of Nutrition International Society of Nutraceutical and Functional Foods (ISNFF) Member Society of Toxicology New York Academy of Sciences American Institute of Chemical Engin
List of Publications/ Patents/ Books: Peer-Reviewed Publications: 448
- Please see Google Scholar (Citation 35334; h-index 89; i10-index 279 https://scholar.google.com/citations?user=Qhe_0jwAAAAJ&hl=en and https://www.researchgate.net/profile/Debasis-Bagchi/26
- Patents: 20 https://patents.justia.com/inventor/debasis-bagchi
- Books Edited: 46 (Elsevier/Academic Press; CRC Press/Taylor & Francis); Wiley-Interscience
Rajendra Badgaiyan, MD, MBA
BOARD MEMBER
DEPARTMENT OF PSYCHIATRY, CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE, CLEVELAND, OH. USA
Dr. Rajendra D. Badgaiyan, is Professor of Psychiatry at University of Texas Health San Antonio. After completing psychiatry residency training at Harvard Medical School, Dr Badgaiyan joined the faculty of Harvard Medical School, State University of New York at Buffalo, and University of Minnesota. He also served as the Professor of Psychiatry and Chairman of the Department at the hospital affiliated to Icahn School of Medicine at Mount Sinai, New York; Chief of Psychiatry at South Texas Healthcare System at San Antonio, TX and Chairman of Psychiatry department at Case Western Reserve University Cleveland. Dr Badgaiyan developed a novel Neurotransmitter Imaging technique for detection, mapping, and quantification of neurotransmitters released in the live human brain during performance of mental activities. Using this technique, he studies dopaminergic control of conscious and nonconscious cognition and behavior and understanding neuropathology of psychiatric conditions. He received several prizes and awards for research including the prestigious Solomon Prize of Harvard Medical School and BK Anand National Research Prize in India. His research is funded by National Institutes of Health, Department of Veterans’ Affairs, Dana Foundation and other agencies. Dr Badgaiyan has published over 300 research papers and book chapters. He authored a book titled ‘Neuroscience of the Nonconscious Mind’ (Elsevier/Academic Press).
Jag H. Khalsa, MS, PhD, DFISAM
BOARD MEMBER
DEPARTMENT OF MEDCINE, MARYLAND UNIVERSITY SCHOOL OF MEDCINE, BALTIMORE, MD. USA and former Chief Medical Consequences Branch, NIDA (retired)
Currently, Dr. Jag Khalsa serves as an Adjunct Professor at the George Washington University School of Medicine, and Institute of Human Virology, U. Maryland School of Medicine, Baltimore, Maryland, and a Special Volunteer at the National Institute on Drug Abuse (NIDA), NIH. He retired on October 31, 2017, after 30 years as the Chief of the Medical Consequences of Drug Abuse and Infections Branch, NIDA, NIH, DHHS. With 50+ years of experience in drug research, he was responsible for developing/administering a national and international program of clinical research on medical and health consequences of drug abuse and co-occurring infections (HIV, HCV, and others). Prior to joining NIDA in 1987, he served for ~10 years as a pharmacologist/toxicologist assessing safety (carcinogenic/teratogenic) of chemicals [INDs/NDAs] and food additives and clinical evaluator at FDA. He has published in several peer-reviewed journals. He reviews for many journals (e.g., JAM, CJAM, Virology and others) and also serves on editorial boards of Journals of Addiction Medicine, Current Psychopharmacology, Research on HIV/AIDS and Palliative Care, and Frontiers of Neuroscience. He served on numerous Federal and NIH level committees including the HHS Viral Hepatitis Implementation Group (VHIG), National Commission on Digestive Diseases and its two sub-committees (Liver Research, Diabetes Research), Federal Task Force on TB, NIH Steering Committee on Centers for AIDS Research, and Human Microbiome Workgroup. He has received distinguished service awards from the FDA Commissioner, the Directors of NIH and NIDA, Society of Neuro-Immune-Pharmacology (SNIP), Life Time Achievement Awards from SNIP and International Conference on Molecular Medicine (India) and MIT, India; a commendation from the US Congressman Elijah Cummings, Awards of Merit and the Honorary Membership in the International Society of Addiction Medicine (ISAM), Distinguished Fellow (DFISAM), Honorary Membership in Iceland Society of Addiction Medicine, the President of the American Society of Addiction Medicine (ASAM), Certificate of Appreciation from the Office of Assistant Secretary for Health (Drs. Howard Koh and Ron Valdiserri), DHHS, and a lifetime service award from the Society of Nano technology and Personalized Medicine. He has a Ph.D. in Neuropsychopharmacology, a master’s degree in pharmacology/Pharmacognosy (Herbal Pharmacology), bachelor’s degrees in chemistry/Botany and Pharmacy, post-doctoral training in CNS/Cardiovascular pharmacology at SK&F, and Environmental Toxicology at Stanford Research Institute International. Email: jag.khalsa@nih.gov; personal e-mail: jkhalsa@yahoo.com
Edward Justin Modestino, Ph.D., M.S., L.M.H.C., C.Ht.
BOARD MEMBER
DEPARTMENT OF PSYCHOLOGY, CURRY COLLEGE, MILTON, MA.,USA (The College specialized in ADHD & Autism Spectrum Disorder) – Reseach interest is neuroscience
Dr. Modestino is a neuroscientist, professor, and licensed mental health counselor. Dr. Modestino completed two postdoctoral fellowships in neuroimaging: one in psychiatry at UVA and one in neurology at BU. He is currently a senior lecturer of psychology at Curry College in Milton, MA. Also, he is a therapist in a private practice in Stoughton, MA. The focus of Dr. Modestino’s research is on ADHD and related components, including addiction and Reward Deficiency Syndrome (RDS).
https://brainandbehavior.wixsite.com/bandblab
- Neuroscientist and Mental Health Counselor Senior Lecturer of Psychology and Co-director of EEG Lab at Curry College https://www.curry.edu/directory/modestino-edward
- Director of Brain & Behavior Lab https://brainandbehavior.wixsite.com/bandblab
- Licensed Mental Health Counselor at Stoughton Counseling, Inc. https://www.stoughtoncounseling.com/providers Associate Editor for the Journal of Addiction Science
- Editorial Board Member for Current Psychopharmacology Editorial Board of the Journal of Personalized Medicine
- Editorial Board Member of INNOSC Theranostics and Pharmacological Sciences (ITPS)
Nicole Jafari, ED.D., MBA, CMC, PCC
BOARD MEMBER
FOUNDER/PRESIDENT, GLOBAL GROWTH INSTITUTE, INC.; THE CHICAGO SCHOOL OF PROFESSIONAL PSYCHOLOGY, ; EMERITUS PROFESSOR AT THE CALIFORNIA STATE UNIVERSITY, LONG BEACH Intentional Parenting Hardcover – July 1, 2022 by Nicole Jafari (Author), Foojan Zeine (Author), Eileen Manookian (Author) Research interest NEUROSCIENCE OF ADDICTION & PSCHOLOGY
Nicole Jafari holds a doctorate in education specializing in behavioral and developmental psychology. Dr. Jafari has taught various psychology and human development courses encompassing multidisciplinary and cross-cultural contexts for the past twenty-one years. She is an associate professor at the Chicago School of Professional Psychology, Los Angeles campus, teaching doctoral degree students in the applied clinical psychology department. Her research interests include cross-cultural and multi-disciplinary emphasis, life span developmental challenges, parenting strategies, and the association between scientific and spiritual growth. Dr. Jafari has published and co-authored many research articles on children & adolescents and life span developmental topics in various highly regarded scientific and academic journals.
Additionally, she has authored several scholarly books with a global, cultural, and multi-disciplinary perspective of human development. As an international public speaker, she speaks on subjects related to human development (from prenatal to late adulthood), children, youths, and families in today’s multicultural and multi-contextual environment, addressing such issues as mass media, globalization, cultural integration, and effective parenting. In her spare time, Dr. Jafari co-hosts several weekly radio/TV and media broadcast programs on developmental, social, and psychological topics, including parenting, family, child, and adolescents. In other capacities, she has worked or is currently working with several prestigious organizations, including:
- Scientific Conference Co-chair & Researcher: Society of Brain Mapping and Therapeutics organization, a worldwide scientific entity that has been instrumental in the global collaboration of high-caliber scientists in various scientific fields (https://www.worldbrainmapping.org).Links to an external site.
- Advisory Board Member: TREAT California: State funding for California promoting safe, responsible, and ethical strategies for psychedelic medicine research and innovations (https://www.treatcalifornia.orgLinks to an external site.).
- Scientific Advisory Board Member: TRANSPLICEGEN, LLC, a leading organization in genetic testing and pre-addiction assessment
- Founder and president of Cross-Cultural Research and Educational Institute (CREI), a 501c3 non-profit organization that conducts global research, assessment, and educational seminars/workshops.
- She is also the co-founder and CEO of the Global Growth Institute, an organization dedicated to helping individuals, teams, and organizations through counseling, consulting, and coaching with a multicultural, multidisciplinary, and global perspective.
KAI-UWL LEWANDROSKI , MD
BOARD MEMBER
DEPARTMENT OF ORTHOPAEDICS, FUNDACIÓN UNIVERSITARIA SANITAS, BOGOTÁ, DC, COLOMBIA ; DEPARTMENT OF ORTHOPEDICS, HOSPITAL UNIVERSITÁRIO GAFFRE E GUINLE, UNIVERSIDADE FEDERAL DO ESTADO DO RIO DE JANEIRO, BRAZIL; CENTER FOR ADVANCED SPINAL SURGERY OF SOUTHERN ARIZONA, TUCSON, UNITED STATES. DR. LEWANDROWSKI is a member of the National Academy of Medicne (Columbia & Brazil) Research interest IS PAIN AND PHARMACOGENOMICS
ALIREZA SHARAFSHAH, PhD
BOARD MEMBER
CELLULAR AND MOLECULAR RESEARCH CENTER, SCHOOL OF MEDICINE, GUILAN UNIVERSITY OF MEDICAL SCIENCES, RASHT, IRAN. Reseach interest PHARMACOGENOMICS
FOOJAN ZEINE, PSCH D, LMFT
BOARD MEMBER
DEPARTMENT OF HEALTH SCIENCE, CALIFORNIA STATE UNIVERSITY AT LONG BEACH, LONG BEACH, CA, USA. AWARENESS INTEGRATION INSTITUTE, SAN CLEMENTE, CA, USA. Intentional Parenting Hardcover – July 1, 2022 by Nicole Jafari (Author), Foojan Zeine (Author), Eileen Manookian (Author) ORIGINATOR AWARENESS INTEGRATION THERAPY
- Radio / Television Podcast Host
- Research interest -Neuroplasticity and self-identity
ABDALLA BOWIRRAT, MD, PhD
BOARD MEMBER
DEPARTMENT OF MOLECULAR BIOLOGY, ADELSON SCHOOL OF MEDICINE, ARIEL UNIVERSITY, ARIEL, ISRAEL.
Research Interest -molecular biology and addiction psychiatry
P ANAYOTIS K. THANOS, PhD
BOARD MEMBER
SENIOR RESEARCH SCIENTIST AT UNIVERSITY AT BUFFALO, THE STATE UNIVERSITY OF NEW YORK AND ASSOCIATE PROFESSOR OF THE DEPARTMENT OF PHARAMACOLOGY & TOXICOLOGY .JACOB SCHOOL OF MEDCINE ,UNIVERSITY OF BUFFALO AND HONORARY PROFESSOR ARILA UNIVERSITYISREAL.
PERFORMED THE FIRST EVER GENETHERAPY WITH DRD2 GENE SHOWING EXTROADINARY REDUCTION OF ALCHOL AND COCAINE INTAKE IN ANMALS
Dr. Thanos is the Director of Behavioral Neuropharmacology and Neuroimaging Laboratory on Addictions, Clinical Research Institute on Addictions.
Research interests: Glucose Metabolism, Behavioral Neuroscience, Dopamine, Neuropsychopharmacology, Brain Mapping, Functional Neuroimaging, Neurobiology, genetics and exercise.
DANIEL SIPPLE, DO, FABPMR, DABPM
BOARD MEMBER
MIDWEST SPINE AND BRAIN INSTITUTE AND HYPERCHARGE CLINICS
DR. SIPPLE’S INTERESTS INCLUDE MEDICAL-LEGAL SERVICES, LEADING-EDGE RESEARCH, INNOVATIVE ENTREPRENEURSHIP, PLUS NATIONAL AND GLOBAL NEUROSCIENCE POLICY. HE FOUNDED ACIES MEDICAL AND INVENTED A LIFE-SAVING NEEDLE.
Research interests; pain, addiction liability , Exercise with Oxygen Therapy, Class IV Laser, NanoVi Structured Water Therapy, Photobiomodulation, NuCalm,
DAVID BARON, DO
BOARD MEMBER
FULL PROFESSOR AND FORMER VICE PRESIDENT AND PROVOST WESTERN UNIVERSITYH EALTH SCIENCES, POMONA., CALIFORNIA.FORMER DEPARTMENT OF PSYCHIATRY AT THE KECK SCHOOL OF MEDICINE, INCLUDING VICE DEAN FOR GLOBAL HEALTH, PROFESSOR OF PSYCHIATRY AND NEUROSURGERY, VICE CHAIR OF THE DEPARTMENT, AND CHIEF OF SERVICE AT KECK-USC HOSPITAL. HE IS THE FORMER DEPUTY CLINICAL DIRECTOR OF THE NATIONAL INSTITUTE OF MENTAL HEALTH (NIMH), FORMER PRESIDENT OF THE AMERICAN COLLEGE OF NEUROPSYCHIATRY. FORMER OLYMPEAN IN SWIMMING NOW A MEMBE ROF THE OLYMPIC COMMITTEE GLOBAL.
Dr. Baron was named a National Fulbright scholar in 2017-18 and conducted his research as Distinguished Chair in Brain Research at the University of Calgary. He also is the recipient of a Fulbright Specialist Award.
RESEARCH INTEREST: sports psychiatry and addiction liability, neurobiology, genetics and recovery science. In conjunction with DR. Blum published 103 Pubmed listed article.